HYPERHIDROSIS SCIENCE: Hyperhydrosis research, treatments - excessive sweating knowledge
DR. STOLL'S HYPERHIDROSIS ARTICLE INDEX
- Is previous throacic sympathectomy a risk factor for exertion?
- Treatment of palmar hyperhidrosis: T(4) level compared with T(2) and T(3).
- Severe Pomphylox Following Endoscopic Thoracic Sympathectomy for Hyperhidrosis
- Repeat Liposuction-Curettage Treatment of Axillary Hyperhidrosis Effectiveness
- Contralateral Hyperhidrosis After Intracerebral Hemmorage
- Facial hyperhidrosis: Best Practice Recommendations and Special Considerations.
- Outpatient Microthoraacosopic Sympathectomy for Palmar Hyperhidrosis
- Use of Oral Glycopyrronium in Hyperhidrosis
- Oxybutynin for Patients with Hyperhidrosis in One Case Study
- Paroxetine Useful for Palmar-Plantar Hyperhidrosis in One Case Study
- Thoracic Sympathicolysis for Primary Hyperhydrosis
- Improved Quality of Life After Sympathetic Block for Upper limb Hyperhidrosis.
- Surgical Treatment of Axillary Hyperhidrosis
- Mydriasis and Accommodative Failure from Exposure to Topical Glycopyrrolate Used in Hyperhydrosis.
- Facial Hyperhydrosis-Induced Social Fear Alleviated with Topiramate.
- Treatment of Inguinal Hyperhidrosis or HH with Botulinum Toxin Type A.
- Hyperhidrosis in Parkinson's Disease.
- Hyperhydrosis: A Few and Often Early Symptom in Fabry Disease.
HYPERHIDROSIS KNOWLEDGE AND SCIENCE
JUNE 2006: Sweating associated with diseases
Medical Publication:
Hyperhidrosis: a new and often early symptom in Fabry disease.
International Journal of Clinical Practice. 60(9): 1053-9, 2006.
Synopsis: Fabry disease is an inherited disorder that affects the heart, kidneys and nerves, and often times leads to an increase in sweating and even hyperhidrosis.
Fabry disease results from an enzyme deficiency that leads to the deposit of fatty substances in the blood vessels. One of the hallmark symptoms of Fabry disease is hypohidrosis, that is, an increase in sweating. These authors described the unusual cases of Fabry disease patients with hyperhidrosis, i.e. excessive sweating. They found that females more often had hyperhidrosis than males, and the onset of the excessive sweating appears in childhood or adolescence. The authors do not postulate why some people with Fabry disease exhibit excessive sweating, while most people with the disease exhibit decreased sweating.
Conclusion: The authors present several patients with hyperhidrosis who suffer from a genetic disorder that usually presents itself with decreased sweating. Their parting comment is very telling. Basically, concerning hyperhidrosis future research, the efficacy of enzyme replacement therapy should be assessed. Replacing the missing enzyme in Fabry disease, which is easier said than done, should yield some interesting data regarding the treatment and causes of sweating disorders, such as excessive sweating or hyperhidrosis.
MegaDry™ hyperhidrosis
control for your excessive sweating.
Allow one to two weeks for delivery.
Sweating treatment may last up to
six months, depending upon use.
Price: $38.95 $19.95 for 1.2 fl. oz. bottle
Shipping/Handling:
Domestic: $2.95
International: $6.95